Author Archives: wpadmin

ThomasLloyd appoints Vivienne Maclachlan as Group Chief Financial Officer

London, Zurich, 21st December 2020 – ThomasLloyd has made a significant addition to its executive management team with the appointment of Vivienne Maclachlan as Group Chief Financial Officer. An accomplished British professional with Scottish roots, Ms. Maclachlan will take on the role of Group Chief Financial Officer (CFO) and become a member of the Executive… Read More »

TERRE DES FEMMES breaks the silence about domestic violence during what is supposed to be the most peaceful time of the year

Berlin, December 18th 2020: TERRE DES FEMMES – Menschenrechte für die Frau e. V. opens the art exhibition “UNBREAK – take a closer look & break the cycle of domestic violence” (https://cloud.achtung.de/s/g7PanPkDDnf28pe) in downtown Munich, together with the agencies thjnk and achtung! Mary, the artist Simon Berger, and the long-time TERRE DES FEMMES activist Romy… Read More »

People with NNRTI resistance have poorer responses to dolutegravir, South African study finds

People with HIV who already have resistance to a non-nucleoside reverse transcriptase inhibitor (NNRTI) when they start first-line antiretroviral treatment containing the integrase inhibitor dolutegravir were less likely to achieve viral suppression, a large clinical trial in South Africa has reported. NNRTI resistance has not been shown to affect responses to dolutegravir-based treatment previously. The… Read More »

More weight gain in people starting HIV treatment with newer integrase inhibitors or darunavir

A US study has concluded that weight gain is greater by around 2 to 4 kg in HIV-positive people taking bictegravir or dolutegravir as part of their first antiretroviral therapy (ART), compared to their counterparts using other drug regimens. A similar effect was reported in those using the protease inhibitor darunavir. The study led by… Read More »